Exploiting the proteomics revolution in biotechnology: from disease and antibody targets to optimizing bioprocess development

- Comparative proteomics identifies novel cancer and disease targets.
- Proteomics represent a new tool for mAb discovery.
- Proteomics can optimize biotherapeutics development.
- Improvements in CHO and E. coli proteome databases aid bioprocessing.